sarpogrelate has been researched along with Retinal Degeneration in 2 studies
sarpogrelate: structure given in first source
Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
| Excerpt | Relevance | Reference |
|---|---|---|
| "BALB/c mice were dosed intraperitoneally with 5, 15, 30, 40, or 50 mg/kg sarpogrelate 48, 24, and 0 hours prior to bright light exposure (10,000 lux) as well as 24 and 48 hours after exposure." | 1.42 | Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy. ( Coyner, AS; Datta, S; Gale, MJ; Ku, C; Nicholson, A; Pennesi, ME; Regis, D; Ryals, RC; Sinha, W; Tullis, BE; Wen, Y; Yang, P, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ku, CA | 1 |
| Ryals, RC | 2 |
| Jiang, D | 1 |
| Coyner, AS | 2 |
| Weller, KK | 1 |
| Sinha, W | 2 |
| Robb, BM | 1 |
| Yang, P | 2 |
| Pennesi, ME | 2 |
| Tullis, BE | 1 |
| Gale, MJ | 1 |
| Nicholson, A | 1 |
| Ku, C | 1 |
| Regis, D | 1 |
| Datta, S | 1 |
| Wen, Y | 1 |
2 other studies available for sarpogrelate and Retinal Degeneration
| Article | Year |
|---|---|
The Role of ERK1/2 Activation in Sarpogrelate-Mediated Neuroprotection.
Topics: Acrylonitrile; Aniline Compounds; Animals; Benzamides; Blotting, Western; Diphenylamine; Electroreti | 2018 |
Sarpogrelate, a 5-HT2A Receptor Antagonist, Protects the Retina From Light-Induced Retinopathy.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Disease Models, Animal; Electroretinography; Inject | 2015 |